” Breakthrough in Rare Disease Therapeutics Created by Novel Technology or Modality “
Kiyosumi Takaishi, Ph.D.
Laboratories Senior Director, DAIICHI SANKYO CO., LTD.R&D
Division Rare Disease & LCM
Date : 11th November, 2019 4:00 p.m.~
Location : IMCR Gunma Univ. 1F Conference Room